positive
Recently
Strong grey market interest puts Corona Remedies IPO in investor spotlight on opening day
Corona Remedies IPO opened on December 8 with a strong grey market premium near 290 rupees, signalling solid demand ahead of its scheduled listing on December 15.
Market participation picked up on December 8 as Corona Remedies opened its public issue for subscription, seeking to raise 655.37 crore rupees through a complete offer for sale. The price band has been fixed between 1,008 and 1,062 rupees per share, with a minimum application size of 14 shares. Investor sentiment remained firm as the grey market premium hovered near 290 rupees, implying a potential listing price around 1,352 rupees.